[Pj-017] 一般演題ポスターセッション（日本語）017

[Pj-017-1] 再発性のMS患者に対するオファツムマブ長期データ：服薬遵守状況と投与継続率 [アンコール演題]

井上 聖香¹, Alvarez Enrique², Hersh Carrie M.³, Robertson Derrick⁴, Das Gupta Ayan⁵, Hu Xixi⁶, Zielman Ronald⁷, Boer Ibolya⁸, Cheadle Andy⁶, Cohen Jeffrey A.⁹ (1.ノバルティス ファーマ株式会社, 2.University of Colorado School of Medicine, Aurora, CO, USA, 3.Cleveland Clinic Mellen Program for MS, Lou Ruvo Center for Brain Health, Las Vegas, NV, USA, 4.Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, 5.Novartis Healthcare Pvt. Ltd., Hyderabad, India, 6.Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 7.Novartis Pharma B.V., Amsterdam, the Netherlands, 8.Novartis Pharma AG, Basel, Switzerland, 9.Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA)